AEI Alset Inc. Insider Trading

CEO Chan Heng Fai Ambrose sold 500,000 shares at $2.67 on 2025-09-12; stock now $4.27 (+0.0% from 52-week high), up +261.9% over 30 days.

Chan Heng Fai Ambrose, CEO of Alset Inc., sold 500,000 shares at $2.67 on 2025-09-12, reducing his holdings from 31.82M to 31.32M shares (-1.6% of pre-transaction holdings). The sale occurred during a period of sharp upward price momentum: the stock has risen +261.9% over the past 30 days and +357.5% over the past 90 days, now trading at $4.27, which matches the 52-week high. At the time of sale, the stock was valued at approximately $2.67, well below its current price, suggesting the insider sold during a relative low point prior to subsequent acceleration. Across his 11 prior open-market sales on other tickers, his well-timed sell rate was 72.73% (higher is better for sells); however, at this specific ticker (AEI), only 1 of 4 prior measurable buys were well-timed at the 90-day horizon. The company remains unprofitable (full-year net income was $-8,221,441.00, latest quarter revenue was $1,098,962.00) and revenue declined -4.4% annually, creating a structural disconnect between the stock's recent momentum and underlying operating performance.

CEO Chan Heng Fai Ambrose buys 33,000 shares at $1.29; stock now $1.18, down 5.6% in 30 days.

Chan Heng Fai Ambrose, the CEO, purchased 33,000 shares at $1.29, increasing his holdings from 31,789,903 to 31,822,903 shares. The stock has declined to $1.18, representing a -5.6% change over the past 30 days. His cross-ticker track record shows 9 prior buys averaging -31.8% over 30 days with a 22.22% win rate, while his same-ticker history at AEI shows 2 of 5 prior buys were well-timed at the 90-day mark. Notably, Alset Inc. reported a net loss of $-8.2M on quarterly revenue of $1.1M and revenue declined 4.4% year-over-year, creating a backdrop of operational weakness rather than growth signals.

CEO buys 50,000 AEI shares at $1.23 on 2025-02-13; stock now $1.16; 5 purchases in 3 weeks as fundamentals improve sharply.

Chan Heng Fai Ambrose purchased 50,000 shares at $1.23 on 2025-02-13, adding to a pattern of five buys within three weeks (2025-01-22 through 2025-02-13), totaling significant accumulated shares at AEI. The stock has declined 5.7% since the transaction (from $1.23 to $1.16), though it remains up 41.4% over the past 30 days and is still -41.1% from its 52-week high of $1.97. The rapid accumulation pattern is contextualized by strong recent fundamentals: revenue surged 393.0% year-over-year to $5.0M in the latest quarter, with net income of $1.7M, though the company was unprofitable over the most recent full fiscal year. The extended buying across a compressed timeframe alongside improving quarterly trends warrants monitoring, especially given the gap between the transaction price and the earlier 52-week high.

CEO Chan Heng Fai Ambrose buys 20,244 shares of Alset Inc. at $1.07; executes 5th consecutive AEI purchase in 3 weeks

Chan Heng Fai Ambrose purchased 20,244 shares of Alset Inc. (AEI) at $1.07 on 2025-02-12, increasing his holdings from 6,329,498 to 6,349,742 shares. This transaction is part of a striking pattern: the CEO has executed 5 open-market buys in 15 days (spanning 2025-01-22 through 2025-02-13), with no selling activity during the same window. The stock has appreciated 31.8% over the past 30 days and trades at $1.16, well above the recent 52-week low of $0.46, though still -41.1% below the 52-week high of $1.97. Fundamentals show revenue of $4,960,711.00 and net income of $1,716,363.00 in the latest quarter, with annual revenue growth of +393.0%, though the company was unprofitable over its most recent full fiscal year. The concentrated buying pattern across multiple tranches warrants attention as a potential signal of perceived value or stabilization, particularly given the company's recent profitability swing and growth trajectory, but outcomes for the same-ticker buys are not yet measurable.

CEO Chan Heng Fai Ambrose buys 291,060 shares at $1.01 avg for $294,149.40; stock down 30.2% in 90 days

CEO Chan Heng Fai Ambrose executed 2 separate purchases totaling 291,060 shares for $294,149.40, increasing holdings by 4.8% to 6.33M shares. The transactions occurred at a blended average price of $1.01, but the current price of $0.95 reflects a decline of 51.8% from the 52-week high and a 90-day decline of -30.2%. Within his same-ticker history at AEI, 2 of 3 prior measurable buys (August 2024) achieved positive 90-day returns of +27.8% and +26.0%, though his cross-ticker track record shows a 90-day win rate of 71.43%, suggesting selective execution success. The company is fundamentally challenged: unprofitable on a full-year basis despite recent quarterly profitability ($1.7M net income on $5.0M revenue) and rapid annual revenue growth of +393.0%, creating an asymmetry between headline growth and bottom-line sustainability.

CEO Chan Heng Fai Ambrose buys 100,000 AEI shares at $0.93; stock down 56.4% from high despite 393% annual revenue growth

CEO Chan acquired 100,000 shares at $0.93 on 2025-01-27, the fifth open-market purchase at AEI within the past six months. The company has posted exceptional top-line growth (+393.0% annual revenue growth) and returned to profitability with $1,716,363.00 net income in the latest quarter, yet the stock has declined 56.4% from its 52-week high and trades at $0.86, down 31.7% in the last 30 days. Chan's prior four buys at this ticker showed a 75% win rate on 90-day returns (3 of 4 measurable outcomes were positive), establishing a pattern of well-timed entry points at AEI specifically. The repeated buying into a declining price despite strong operational fundamentals presents a tension between operational performance and market sentiment that deserves investor attention.

CEO Chan Heng Fai Ambrose buys 50,000 shares of AEI at $0.85 amid -49.7% 90-day decline

CEO Chan Heng Fai Ambrose purchased 50,000 shares at $0.85 on 2025-01-22, increasing his holdings to 5,938,438 shares. The purchase occurs at $0.85, down 56.8% from the 52-week high of $1.97 and following a 90-day decline of -49.7%. At AEI specifically, Chan's prior 5 trades show mixed timing results: 3 of 5 prior buys achieved positive 90-day returns, indicating some historical ability to identify entry points at this ticker. The company reported quarterly revenue of $5.0M and quarterly net income of $1.7M, though it was unprofitable on a full-year basis. The stock's extended decline and the CEO's decision to accumulate additional shares at depressed levels provide concrete facts for investor evaluation; the significance is tempered by the modest purchase size relative to his 5.94M total position and the company's thin profitability picture.

CEO Chan Heng Fai Ambrose bought 12,867 shares of AEI at $1.17; 5 buys in 27 days as stock rallied +69.3% in 90 days.

Chan Heng Fai Ambrose, CEO of Alset Inc., purchased 12,867 shares at $1.17 on 2024-08-22, the third of five insider buys within a concentrated 27-day window (2024-06-26 through 2024-08-22). The purchase follows strong recent price momentum, with the stock up +69.3% over the prior 90 days and +15.1% over the past 30 days, though it remains -30.5% below its 52-week high of $1.97. The company reported negative net income of $-1,239,114.00 in the latest quarter despite +393.0% annual revenue growth, indicating profitability remains elusive. The timing and cadence of these repeated open-market purchases during a rising market—combined with the company's unprofitable state and -33.5% and -13.8% negative 30-day returns on his two prior AEI purchases in June—present a pattern warranting scrutiny of the underlying business trajectory.

CEO Chan Heng Fai Ambrose bought 2,983 shares of AEI at $0.95 on 2024-08-20; stock is -38.6% from 52-week high and company posted -$1.2M net income last quarter.

Chan Heng Fai Ambrose, CEO, purchased 2,983 shares at $0.95 for $2,833.85 on 2024-08-20, a modest open-market buy. The purchase occurred as the stock trades at $1.21, down 38.6% from its 52-week high and down 0.8% over the prior 30 days, though up 80.6% over 90 days. Across his prior trades at Alset Inc., the same ticker, Chan has incurred losses: his 2024-06-27 buy posted a -33.5% 30-day return, and his 2024-06-26 buy returned -13.8% at 30 days; no prior buys at this ticker have reached a measurable 90-day mark with positive outcomes. The company itself is loss-making: net income was -$1,239,114.00 last quarter, and full-year net income was negative, while revenue of $1,127,046.00 suggests the business is in early stage or distressed. The timing of this buy relative to the 90-day performance of his prior AEI purchases offers no evidence of a pattern of well-timed accumulation at this ticker.

CEO Ambrose Chan purchases 27,413 shares across 2 transactions (Aug 16–19) at blended $0.94, raising stake to 5.87M shares as stock down 51.8% from 52-week high.

Chan Heng Fai Ambrose, Chief Executive Officer, executed 2 separate purchases totaling 27,413 shares for $25,871.70 on August 16 and August 19, 2024, at prices of $0.90 and $0.96 respectively. His holdings increased from 5.85M to 5.87M shares (+0.5% vs pre-transaction holdings), reflecting a modest net addition to an already substantial position. The timing coincides with significant recent price weakness: the stock is -51.8% from its 52-week high and down 22.1% over the prior 30 days, yet up 81.3% over 90 days. His same-ticker trading history at AEI shows mixed results—prior purchases in June ranged from flat (+0.0%) to down 33.5% at the 30-day mark, with none yet measurable at 90 days, providing no clear pattern of successful execution. Fundamentally, the company generated $1.1M in quarterly revenue but reported a $-1.2M net loss, indicating operational challenges despite 393.0% annual revenue growth.